Protonitazepyne

In this article, we want to address the topic of Protonitazepyne to offer a broad and detailed vision of this topic that is so relevant today. From its origins to its impact on society, through its evolution over time, we aim to analyze every aspect related to Protonitazepyne to provide our readers with a complete and up-to-date perspective. Through data, studies and testimonies, we aim to shed light on Protonitazepyne and its implications, with the aim of providing enriching and valuable knowledge to those interested in delving deeper into this topic. It is our hope that this article serves as a starting point for a critical and constructive reflection on Protonitazepyne, stimulating debate and the search for solutions around this issue.

Protonitazepyne
Identifiers
  • 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzoimidazole
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H28N4O3
Molar mass408.502 g·mol−1
3D model (JSmol)
  • CCCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN4CCCC4)C=CC(=C3)(=O)
  • InChI=1S/C23H28N4O3/c1-2-15-30-20-8-5-18(6-9-20)16-23-24-21-17-19(27(28)29)7-10-22(21)26(23)14-13-25-11-3-4-12-25/h5-10,17H,2-4,11-16H2,1H3
  • Key:KCRWXNIIXGBPID-UHFFFAOYSA-N

Protonitazepyne (N-pyrrolidino protonitazene) is a benzimidazole derivative with opioid effects, which has been sold as a designer drug over the internet, first being mentioned in mid 2022 and definitively identified in drug seizures in Canada in early 2023 and Ireland in late 2023.[1] It is an analogue of etonitazene where the ethoxy group has been extended to propoxy, and the N,N-diethyl substitution has been cyclised into a pyrrolidine ring. While formal studies into its pharmacology have yet to be carried out, it is believed to be slightly less potent than the ethoxy analogue etonitazepyne but still a potent opioid.[2][3]

See also

References

  1. ^ Killoran S, McNamara S, Kavanagh P, O'Brien J, Lakes R (May 2024). "Identification of N-pyrrolidino protonitazene in powders sold as heroin and associated with overdose clusters in Dublin and Cork, Ireland". Drug Testing and Analysis. doi:10.1002/dta.3707. PMID 38769669.
  2. ^ "Early signal alert: Emergence of online mentions of Protonitazepyne". National Drug Early Warning System. 29 July 2022.
  3. ^ "Analyzed Drug Report" (PDF). Drug Analysis Service and Cannabis Laboratories. Health Canada. April–June 2023.



Stub icon

This analgesic-related article is a stub. You can help Wikipedia by expanding it.